Could targeted drugs spare brain cancer patients from radiation after surgery?
NCT ID NCT07655583
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study explores whether people with melanoma or non-small cell lung cancer that has spread to the brain can safely skip stereotactic radiosurgery (focused radiation) after having a brain tumor surgically removed. Instead of radiation, participants receive systemic therapy tailored to their cancer type—such as immune checkpoint inhibitors for melanoma or targeted pills for certain lung cancers. The goal is to see if these drugs alone can prevent the tumor from coming back at the surgical site, potentially avoiding the side effects of radiation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
systemic therapy (immune checkpoint inhibitors for melanoma; osimertinib for EGFR-mutant NSCLC; brigatinib, alectinib, or lorlatinib for ALK-positive NSCLC)
What this could lead to
If successful, this approach could allow some patients to avoid brain radiation after surgery, relying instead on targeted drugs or immunotherapy to prevent recurrence.
What could go wrong
This is a very small pilot study with only 20 participants, so results may not apply broadly. The cancer could still return in the brain without radiation, and the drugs have their own side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States